Biotechnology Assets SA
MAD:BST
Biotechnology Assets SA
Research & Development
Biotechnology Assets SA
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Biotechnology Assets SA
MAD:BST
|
Research & Development
-€7.8k
|
CAGR 3-Years
8%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Grifols SA
MAD:GRF
|
Research & Development
-€373m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-6%
|
|
|
Oryzon Genomics SA
MAD:ORY
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pharma Mar SA
MAD:PHM
|
Research & Development
-€93.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-5%
|
|
Biotechnology Assets SA
Glance View
Biotechnology Assets SA operates as a biopharmaceutical company. The company is headquartered in Jerez De La Frontera, Cadiz and currently employs 32 full-time employees. The company went IPO on 2011-06-14. The Firm’s main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The Company, through its subsidiaries, is also present in Luxembourg, Hong Kong and USA.
See Also
What is Biotechnology Assets SA's Research & Development?
Research & Development
-7.8k
EUR
Based on the financial report for Jun 30, 2025, Biotechnology Assets SA's Research & Development amounts to -7.8k EUR.
What is Biotechnology Assets SA's Research & Development growth rate?
Research & Development CAGR 5Y
24%
The average annual Research & Development growth rates for Biotechnology Assets SA have been 8% over the past three years , 24% over the past five years .
